Skip to main content

Table 1 Anti-HBs titres in preS1 (21–32, 32–47 and 94–117) reactive sera compared with non-reactive sera from newborns vaccinated with Bio-HepB™ vaccine

From: PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen

  Reactive Non-reactive Probability
Anti-preS1 (21–32) n = 14 n = 14  
Anti-HBs IU/L 15 841 ± 4 023 16 026 ± 7 859 ns
Anti-preS1 (32–47) n = 15 n = 13  
Anti-HBs IU/L 24 550 ± 7 375 5 991 ± 1 530 p < 0.05
Anti-preS1 (94–117) n = 12 n = 16  
Anti-HBs IU/L 19 464 ± 5 280 13 286 ± 6 533 ns
  1. ns = not significant
  2. Anti-HBs (mean ± SEM)